Apellis Pharmaceuticals (APLS) Q1 2026 Earnings

Feb 24Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.74
0.06
0.87
1.67

Details

Expected EPS
-0.374009
Actual EPS
-0.47
Surprise EPS
-0.1
Surprise Percent
-25.67%

Description

⁨Apellis Pharmaceuticals⁩ (⁦APLS⁩) has reported earnings of ⁦-0.47⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts